Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yang-I Biotech is a Taiwan-based biotechnology company specializing in the development of advanced diagnostic tools for precision medicine, particularly in the field of liquid biopsy. The company's core technology revolves around the isolation and analysis of circulating tumor cells (CTCs) from blood samples, providing a non-invasive method for cancer screening, monitoring, and treatment guidance. Their flagship products include automated cell-sorting systems designed to capture rare cells with high purity and viability. By integrating microfluidics and proprietary enrichment techniques, Yang-I aims to improve the accuracy of early cancer detection and personalized oncology care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yang I..